An expert discussion not to be missed (if you’re in Lisbon!) 12 Sept 2024

Join the Fireside Chat between our CEO John W. Hadden II and Chris Williams, Chief Business Officer at Autolus Therapeutics about Autolus' journey as a trailblazer in cell therapy.

12th September, 13:45 – 15:00, Advanced Therapies Europe, Lisbon
Session Title: Flexibility in Action: Harnessing Adaptive Vector Platforms for Gene Therapy Manufacturing

Presentations by
Simon Briggs, Director Advanced Analytics, Orchard Therapeutics - U.S.
Cedrick Rousseaux, Innovation, Analytical, and Process Development Director, SK pharmteco
Su Xiao, Chief Technology Officer, Neurophth Therapeutics / 纽福斯生物科技有限公司

Fireside Chat
and
15 minutes for Q&A

https://lnkd.in/e4r975Kz

Farzin Farzaneh, PhD Traci Kyes Makis Sigalas Phacilitate Alliance for Regenerative Medicine #ate24 #advancedtherapies24 #lisbon #celltherapy #viralvectors #cellandgenetherapy